S&P 500   3,957.45 (+0.60%)
DOW   33,714.94 (+0.35%)
QQQ   282.72 (+0.78%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,957.45 (+0.60%)
DOW   33,714.94 (+0.35%)
QQQ   282.72 (+0.78%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,957.45 (+0.60%)
DOW   33,714.94 (+0.35%)
QQQ   282.72 (+0.78%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,957.45 (+0.60%)
DOW   33,714.94 (+0.35%)
QQQ   282.72 (+0.78%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
NASDAQ:PYPD

PolyPid - PYPD Stock Forecast, Price & News

$0.75
-0.05 (-6.25%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.72
$0.77
50-Day Range
$0.66
$1.29
52-Week Range
$0.65
$7.75
Volume
9,652 shs
Average Volume
37,100 shs
Market Capitalization
$14.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.63

PolyPid MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
1,450.0% Upside
$11.63 Price Target
Short Interest
Healthy
3.60% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.09) to ($0.96) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

255th out of 1,022 stocks

Surgical & Medical Instruments Industry

29th out of 101 stocks

PYPD stock logo

About PolyPid (NASDAQ:PYPD) Stock

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Receive PYPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyPid and its competitors with MarketBeat's FREE daily newsletter.

PYPD Stock News Headlines

PolyPid Ltd. (PYPD) Q3 2022 Earnings Call Transcript
PolyPid Announces Cost Reduction Plan - GlobeNewswire
PolyPid Announces Cost Reduction Plan
PolyPid Ltd. Ordinary Shares (PYPD)
See More Headlines
Receive PYPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyPid and its competitors with MarketBeat's FREE daily newsletter.

PYPD Company Calendar

Last Earnings
11/10/2021
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/08/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PYPD
Fax
N/A
Employees
75
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.63
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+1,450.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-42,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.11 per share

Miscellaneous

Free Float
N/A
Market Cap
$14.66 million
Optionable
Not Optionable
Beta
1.29

Key Executives

  • Ms. Dikla Czaczkes Akselbrad (Age 49)
    Chief Exec. Officer
    Comp: $417.38k
  • Ms. Dalit Hazan (Age 51)
    Exec. VP of R&D and Clinical & Regulatory Affairs
    Comp: $280.56k
  • Mr. Ori Warshavsky (Age 44)
    Chief Operating Officer - US
    Comp: $414.44k
  • Mr. Jonny Missulawin
    Sr. VP of Fin.
  • Evgeny Valdman
    Exec. VP of Operations
  • Dr. Malka Reichart Ph.D.
    Scientific Director
  • Ms. Orna Blum
    Legal Counsel
  • Ms. Rivi Lev-ari
    VP of Human Resource
  • Dr. Jean-Marc Hagai Pharm.D.
    Chief Commercial Officer













PYPD Stock - Frequently Asked Questions

Should I buy or sell PolyPid stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PolyPid in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PYPD shares.
View PYPD analyst ratings
or view top-rated stocks.

What is PolyPid's stock price forecast for 2023?

4 brokers have issued 12-month target prices for PolyPid's stock. Their PYPD share price forecasts range from $2.50 to $25.00. On average, they anticipate the company's share price to reach $11.63 in the next year. This suggests a possible upside of 1,450.0% from the stock's current price.
View analysts price targets for PYPD
or view top-rated stocks among Wall Street analysts.

How have PYPD shares performed in 2022?

PolyPid's stock was trading at $5.74 at the start of the year. Since then, PYPD stock has decreased by 86.9% and is now trading at $0.75.
View the best growth stocks for 2022 here
.

When is PolyPid's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our PYPD earnings forecast
.

How were PolyPid's earnings last quarter?

PolyPid Ltd. (NASDAQ:PYPD) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.66) by $0.13. During the same quarter in the previous year, the business earned ($0.35) earnings per share.

What other stocks do shareholders of PolyPid own?
When did PolyPid IPO?

(PYPD) raised $50 million in an initial public offering (IPO) on Friday, June 26th 2020. The company issued 3,100,000 shares at $15.00-$17.00 per share. Barclays and BMO Capital Markets acted as the underwriters for the IPO and Raymond James, National Securities Corporation, Oddo BHF and A.G.P. were co-managers.

What is PolyPid's stock symbol?

PolyPid trades on the NASDAQ under the ticker symbol "PYPD."

Who are PolyPid's major shareholders?

PolyPid's stock is owned by a variety of institutional and retail investors. Top institutional investors include Silverarc Capital Management LLC (0.00%), Raymond James Financial Services Advisors Inc. (0.17%), XR Securities LLC (0.00%), Group One Trading L.P. (0.00%) and Citadel Advisors LLC (0.00%).

How do I buy shares of PolyPid?

Shares of PYPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PolyPid's stock price today?

One share of PYPD stock can currently be purchased for approximately $0.75.

How much money does PolyPid make?

PolyPid (NASDAQ:PYPD) has a market capitalization of $14.66 million. The company earns $-42,600,000.00 in net income (profit) each year or ($2.43) on an earnings per share basis.

How can I contact PolyPid?

PolyPid's mailing address is 18 HASIVIM STREET P.O BOX 7126, PETACH TIKVA L3, 4959376. The official website for the company is www.polypid.com. The company can be reached via phone at 908-378-9530 or via email at ir@polypid.com.

This page (NASDAQ:PYPD) was last updated on 12/8/2022 by MarketBeat.com Staff